A History of Innovation Mission & Core Values Notable Facts & Statistics Leadership Our Directory Accreditation Giving Careers at MCPHS University Important Notices Contact

Our Directory

Bio

Matthew Silva, PharmD, RPh, BCPS
Professor of Pharmacy Practice

Department/Office
Pharmacy Practice - 19 Foster Street, DBEN 503
School of Pharmacy
Contact
matt.silva@mcphs.edu
(P)508.373.5669


Schools
School of Pharmacy - Worcester/Manchester

Programs
Pharmacy (PharmD)

Education
PharmD, Northeastern University

Professional Licensure/Certification
APhA Pharmacist Immunization Certification Board Certified Pharmacotherapy Specialist Registered Pharmacist, Commonwealth of Massachusetts Basic Life Support

Areas of Teaching
Pharmacy Practice in Family Medicine/Primary Care/Ambulatory Care
Diabetes and Disease Management
Outpatient Cardiology
Evidence based medicine, biostatistics and meta-analysis


Scholarly Interests
Pharmacy practice in Family Medicine/Primary Care Prevention and treatment of cardiac and metabolic diseases
Diabetes prevention and management
EBM, biostatistics and meta-analysis
Outcomes research and pharmacoeconomics
Technology in the classroom


Peer-Reviewed Articles & Book Chapters
Jarvis CI, Seed SM, Silva MA, Sullivan KM. Educational Campaign for Proper Medication Disposal. J Am Pharm Assoc. 2009;49:65-68.

Larochelle PA, Giang DK, Silva MA, Kcomt M, Malloy MJ, Kay S, Ku MT. Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity. AJPE 2009;73:1-9.

Candib LM, Silva M, Cashman SB, Ellstrom D, Mallett K. Creating Open Access to Exercise for Low-income Patients Through a Community Collaboration for Quality Improvement: If You Build It, They Will Come. Journal of Ambulatory Care Management 2008;2:142-150.

Silva MA, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi PJ. Meta-analysis of drug induced adverse events associated with intensive statin therapy. Clin Ther. 2007;29:253-260.

Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: A meta-analysis. Clin Ther. 2006;28:26-35.

Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manage. 2006; 2(1):39948.

Silva MA, Gandhi PG. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? J Clin Pharm Ther. 2005

Chan KY, Boucher ES, Gandhi PJ, Silva MA. HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. Am J Health Syst Pharm. 2004. 61;1676-81.

Silva MA. PDAs in clinical practice: Applications and trends. Hospital Pharmacy Europe (HPE) 2003. 11;75-77

Silva MA, Maas B. Using personal digital assistants to document pharmacist cognitive services and estimate potential reimbursement. Am J Health-Syst Pharm 2003. 60;911-915


Editorials
Cross J, Donovan JL, Silva MA, Kanaan AO. Pharmacologic management of post-acute coronary syndromes. US Pharm. 2007 32;2:65-78.

Fonseca FA, Izar MC, Silva MA, Karapanos A, Schuster H, Singh D. Invited Commentary; the ARIES Study - Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial. Evid Based Cardiovasc Med 2006


Current Professional Memberships, Service & Leadership
American Association of Colleges of Pharmacy (AACP)
American College of Clinical Pharmacy (ACCP)
American Society of Health-System Pharmacy (ASHP)


Personal Interests
Drums
Music
Computing and medical informatics